A number of anti-seizure medications are considered very safe by doctors and epilepsy specialists, an important consideration given that as many as half of all patients fail to continue their treatment. While Dilantin and Lamictal are known for links to a dangerous skin disorder, patients should also remain wary of Onfi Stevens Johnson Syndrome (SJS) side effects.
Onfi has only recently been approved by the FDA for use by Americans. It is considered a second-line treatment for epilepsy patients who have not responded well to treatments.
Like Dilantin and Lamictal, people who are dealing with seizures should be mindful of the risk of an autoimmune disorder that begins as a rash on the extremities and is accompanied by flu-like symptoms. However, unlike generic options, there is no black-box warning regarding the potential for SJS side effects or, if the condition worsens, toxic epidermal necrolysis, according to Onfi lawsuit lawyers. This lack of information for patients and doctors comes in spite of the fact that there are decades of data regarding the medication in other countries. Still, the major factor for these three drugs may be compliance by patients and the lack of efficacy of these treatments for some people dealing with seizures.
The autoimmune disorder occurs most often when people are either beginning a new drug regimen or when the dosage is titrated up or down. So for patients who do not respond to Lamictal or Dilantin, there is additional risk each time they start one of these medications and that now includes Onfi Stevens Johnson Syndrome side effects. For those who stop taking medications, similar concerns exist.
For many people looking to control their condition, it is important to consult with a doctor about the potential risks. Otherwise, it is important to watch out on a regular basis for any rashes or other signs of these skin disorders.
However, many people may not have been aware of the possibility of problems with these epilepsy treatments. Legal remedies may be available for those who get in touch with Onfi lawsuit lawyers. A free consultation with one is easy to get: fill out the short form at the Stevens Johnson (SJS) & Toxic Epidermal Necrolysis (TEN) Class Action Lawsuit Investigation. You will find out if you are eligible to pursue legal action against the drug maker and obtain damages or a settlement.
ATTORNEY ADVERTISING
Top Class Actions is a Proud Member of the American Bar Association
LEGAL INFORMATION IS NOT LEGAL ADVICE
Top Class Actions Legal Statement
©2008 – 2026 Top Class Actions® LLC
Various Trademarks held by their respective owners
This website is not intended for viewing or usage by European Union citizens.